Literature DB >> 24524994

Predictive parameters of accelerated muscle loss in men-MINOS study.

Alexia Renoud1, René Ecochard2, François Marchand3, Roland Chapurlat1, Pawel Szulc4.   

Abstract

BACKGROUND: Aging-related muscle loss is a public health problem. We investigated the association of lifestyle and hormonal factors with a prospectively assessed muscle loss in older men.
METHODS: Among 608 home-dwelling men, aged 60-85 (mean 68) years, lifestyle and health status were evaluated through a questionnaire. Appendicular skeletal muscle mass was estimated using dual-energy x-ray absorptiometry and calculated as the sum of lean mass of the 4 limbs. Free testosterone concentration was calculated using concentrations of total testosterone and sex hormone-binding globulin. Longitudinal data were analyzed by hierarchical models.
RESULTS: Average muscle loss was 0.63 ± 0.05%/year. The results of our multivariable adjusted analyses showed that muscle loss was higher in men whose leisure physical activity was <15 hours/week versus ≥15 hours/week (-0.76 vs -0.57%/year). Age-related acceleration of muscle loss was greater in men with lower total testosterone levels (<10 vs ≥10 nmol/L: -0.10 vs -0.07%/year/year of age at baseline [age]). Men with lower free testosterone (<75 vs ≥75 pmol/L) had greater age-related acceleration of muscle loss (-0.12 vs -0.08%/year/age). Higher parathyroid hormone concentrations were associated with greater age-related acceleration of muscle loss (≥45 vs <45 pg/mL -0.14 vs -0.12%/year/age). Men with type 2 diabetes had higher age-related acceleration of muscle loss versus men without diabetes (-0.08 vs -0.03%/year/age) (All P values are <.05).
CONCLUSION: In elderly men, low leisure physical activity, type 2 diabetes, low total and free testosterone, and elevated parathyroid hormone concentrations are associated with greater age-related acceleration of muscle loss. These factors are likely to represent real determinants of aging-related muscle loss in men.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Men; Muscle mass; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 24524994     DOI: 10.1016/j.amjmed.2014.02.004

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Estrogens, the be-all and end-all of male hypogonadal bone loss?

Authors:  M R Laurent; E Gielen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2014-11-07       Impact factor: 4.507

2.  Assessing the Risk of Sarcopenia in the Elderly: The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire.

Authors:  A P Rossi; R Micciolo; S Rubele; F Fantin; C Caliari; E Zoico; G Mazzali; E Ferrari; S Volpato; M Zamboni
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 3.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

Review 4.  Determinants of Muscle and Bone Aging.

Authors:  Elizabeth Curtis; Anna Litwic; Cyrus Cooper; Elaine Dennison
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

5.  Endocrine determinants of incident sarcopenia in middle-aged and elderly European men.

Authors:  Evelien Gielen; Terence W O'Neill; Stephen R Pye; Judith E Adams; Frederick C Wu; Michaël R Laurent; Frank Claessens; Kate A Ward; Steven Boonen; Roger Bouillon; Dirk Vanderschueren; Sabine Verschueren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-27       Impact factor: 12.910

6.  Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data.

Authors:  Agnieszka Swiecicka; Mark Lunt; Tomás Ahern; Terence W O'Neill; György Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Michael E J Lean; Neil Pendleton; Margus Punab; Jolanta Slowikowska-Hilczer; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu; Martin K Rutter
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

7.  Role of androgens for urethral homeostasis.

Authors:  Matthias D Hofer; Allen F Morey
Journal:  Transl Androl Urol       Date:  2018-08

8.  The Association between Body Composition using Dual energy X-ray Absorptiometry and Type-2 Diabetes: A Systematic Review and Meta-Analysis of Observational studies.

Authors:  Preeti Gupta; Carla Lanca; Alfred T L Gan; Pauline Soh; Sahil Thakur; Yijin Tao; Neelam Kumari; Ryan E K Man; Eva K Fenwick; Ecosse L Lamoureux
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

9.  Preventive Effects of Low Parathyroid Hormone Levels on Hip Fracture in Patients with Vitamin D Deficiency.

Authors:  Seong-Eun Byun; Soonchul Lee; Ji Wan Kim; Yong-Chan Ha; Chul-Ho Kim; Cheungsoo Ha; Keun Jung Ryu; Jung-Min Koh; Hyung Kyung Kim; Jae Suk Chang
Journal:  J Bone Metab       Date:  2019-05-31

10.  Factors Associated with Sarcopenia and 7-Year Mortality in Very Old Patients with Hip Fracture Admitted to Rehabilitation Units: A Pragmatic Study.

Authors:  Vincenzo Malafarina; Concetta Malafarina; Arantzazu Biain Ugarte; J Alfredo Martinez; Itziar Abete Goñi; M Angeles Zulet
Journal:  Nutrients       Date:  2019-09-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.